Product Description
Quantity: 100 mL Gibco™ HAT Supplement is a liquid mixture of sodium hypoxanthine (5 mM), aminopterin (20 μM) and thymidine (0.
8 mM). HAT-supplemented medium is suitable for post-fusion selection against unfused or self-fused HGPRT–myeloma cells. Hypoxanthine and thymidine supply preformed purines and pyrimidines for DNA synthesis by hybridomas via the salvage pathway that utilizes HGPRT- contributed by the fused spleen cell. Aminopterin, a folic acid antagonist, inhibits thede novonucleoside biosynthesis pathway.
Product UseFor Research Use Only. Not for use in diagnostic procedures.
Dual site cGMP Manufacturing and Quality SystemFor supply chain continuity, we manufacture Gibco™ HAT Supplement at two separate facilities located in Grand Island, NY and Scotland, UK. Both sites are compliant with cGMP manufacturing requirements, are certified to ISO 13485, and are registered with the FDA as medical device manufacturers.
Cell Type: Mammalian Cells
Concentration: 50 X
Quantity: 100 mL
Shelf Life: 14 Months
Shipping Condition: Dry Ice
Form: Liquid
Product Type: HT Supplement
Sterility: Sterile-filtered
pH: 6 to 8
Unit Size: Each
Order Guidelines
1. Price & Stock Available on Request. Click to send email to: service@iright.com
2. Please DO NOT make payment before confirmtaion.
3. Minimum order value of $1,000 USD required.
4. 100% prepayment required.
Collaboration
Tony Tang
Email: Tony.Tang@iright.com
Mobile/WhatsApp/Wechat: +86-17717886924